Target intelligence / Profile preview

Intestinal epithelial apical junctional complex (AJC) (AJC)

Target
AJC
Molecular classification
Protein complex, Other
01

Overview

The intestinal epithelial apical junctional complex (AJC) is a highly specialized structure located at the boundary between the apical and lateral plasma membranes of enterocytes, consisting of the tight junction (TJ) and the adherens junction (AJ) (PubMed: 28414303). The TJ is the most apical component and acts as a primary gatekeeper, regulating the paracellular movement of water, ions, and small molecules through proteins like claudins, occludin, and zonula occludens (ZO) proteins (NIH: NBK547711). Directly below the TJ, the AJ provides the mechanical adhesive force necessary to hold cells together and serves as a hub for intracellular signaling via E-cadherin and catenin proteins (PubMed: 25324231). Maintaining the integrity of the AJC is essential for intestinal homeostasis, as its breakdown leads to increased permeability, allowing pathogens and toxins to trigger systemic immune responses (PubMed: 31076401). This complex is a significant therapeutic target in conditions like celiac disease and inflammatory bowel disease, where drugs like larazotide acetate are used to prevent junctional disassembly (PubMed: 26075968). Other agents, such as lubiprostone, enhance barrier repair by promoting the assembly of these junctional proteins through chloride channel activation (PubMed: 21248765). Therapeutic strategies also include the use of GLP-2 analogs like teduglutide, which stimulate epithelial growth and junctional integrity (PubMed: 24681584).

Other names
Intestinal tight junctionIntestinal adherens junctionIntestinal barrier complexApical junctional complex
02

Mechanism of action

Regulation of paracellular permeability through the stabilization of transmembrane proteins like claudins and occludin, often via zonulin antagonism or activation of chloride channels to promote junctional assembly.

03

Biological functions

Signal transductionOther
04

Disease associations

InflammationInfectionOther
05

Safety considerations

Risk of systemic translocation of luminal pathogensElectrolyte imbalanceOff-target effects on non-intestinal epithelial barriers
06

Interacting drugs

Larazotide acetate

4 more in the full profile.

07

Biomarkers

ZonulinClaudin-3Transepithelial electrical resistance (TEER)Lactulose/Mannitol ratio

Beyond the preview

Go deeper on Intestinal epithelial apical junctional complex (AJC) (AJC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial apical junctional complex (AJC) (AJC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call